Target intelligence / Profile preview

PHD finger protein 11 (PHF11)

Target
PHF11
Molecular classification
Epigenetic reader domain (PHD finger protein), Transcription factor, Zinc finger protein
01

Overview

PHD finger protein 11 (PHF11) is a zinc-binding protein with an extended plant homeodomain (PHD) finger motif, expressed as multiple isoforms through alternative splicing. The PHD finger mediates protein–protein interactions, particularly with methylated histone tails, implicating PHF11 in chromatin-associated functions. PHF11 is critically involved in 5′ end resection at sites of DNA double-strand breaks, acting as a gatekeeper that negotiates RPA-coated DNA repair intermediates, facilitating homologous recombination and maintenance of genomic stability. Additionally, PHF11 regulates Th1-type cytokine gene expression, contributing to T-cell activation and viability, and has been identified as a candidate gene in atopic diseases such as asthma and IgE responsiveness. It also interacts with multiple DNA repair proteins including EXO1, RPA, BARD1, and others. Its malfunction or deficiency could theoretically affect immune function and DNA repair fidelity, with disease associations seen in inflammatory conditions and cancer. Note: There are no direct drug interactions, mechanisms of action, or safety profiles established for active pharmaceutical modulation of PHF11 as of current literature and searchable databases. It is primarily of interest as a molecular target in immunology and DNA repair research.

Other names
APYBCAPIGELIGERIGHERNY-REN-34NYREN34BRCA1 C-terminus-associated proteinRenal carcinoma antigen NY-REN-34
02

Mechanism of action

Not applicable; no reported direct drug modulators. Its principal molecular action is mediation of protein-protein interactions in DNA repair and immune regulation.

03

Biological functions

DNA damage response (double-strand break repair)Regulation of immune response (positive regulator of Th1-type cytokine gene expression)T-cell activation and viabilityProtein–protein interaction (histone recognition)Cell differentiation
04

Disease associations

AsthmaAtopic IgE responsivenessInflammation (associated with immune conditions)Cancer (association noted in renal carcinoma antigen, DNA repair pathways)Other (general genomic stability, autoimmune predisposition)
05

Safety considerations

None specifically reported for therapeutic targetingtheoretical risk includes genomic instability (if modulated inappropriately due to its role in DNA repair)
06

Biomarkers

Associated as a biomarker for IgE responsiveness (atopic conditions and asthma)

Beyond the preview

Go deeper on PHD finger protein 11 (PHF11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PHD finger protein 11 (PHF11).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call